The Journal of Medical Microbiology, Vol 17, Issue 2 113-119, Copyright © 1984 by Society for General Microbiology

JOURNAL ARTICLE

Selective media for the quantitation of bacteria in cystic fibrosis sputum

K. Wong, M. C. Roberts, L. Owens, M. Fife and A. L. Smith

We used selective media together with aerobic and anaerobic incubation for the quantitation of common pathogens in liquefied sputum from children with cystic fibrosis. The accuracy of the technique was verified by reconstruction studies in which laboratory strains with antibiotic-resistance markers were added to sputum from cystic fibrosis patients. Comparison of the numbers of bacteria found on quantitative culture of clinical specimens with the "predominant" organism found on routine culture yielded a poor correlation. When Pseudomonas aeruginosa was the most prevalent on routine culture, it was present in the highest numbers on quantitative culture (mean count = 10(8) cfu/g). However, large numbers of Haemophilus influenzae (mean count = 10(7) cfu/g), Staphylococcus aureus (mean count = 2 X 10(6) cfu/g), and streptococci (mean count = 2 X 10(6) cfu/g) were also present in these cultures. When S. aureus was the predominant organism, H. influenzae and P. aeruginosa were also present in similar numbers (c. 10(7) cfu/g). When H. influenzae was the predominant species on routine culture, the mean count was 7 X 10(6) cfu/g and P. aeruginosa was often completely absent. We conclude that the selective technique permits reliable enumeration of sputum bacteria, and offers a more accurate assessment of the microbial flora of sputum in cystic fibrosis than does simple plating of unhomogenised sputum.

This article has been cited by other articles:

				A. Molina, R. Del Campo, L. Maiz, M.-I. Morosini, A. Lamas, F. Baquero, and R. Canton High prevalence in cystic fibrosis patients of multiresistant hospital-acquired methicillin-resistant Staphylococcus aureus ST228-SCCmecI capable of biofilm formation J. Antimicrob. Chemother., July 21, 2008; (2008) dkn302v1. [Abstract] [Full Text] [PDF]

				A Pye, S L Hill, P Bharadwa, and R A Stockley Effect of storage and postage on recovery and quantitation of bacteria in sputum samples J. Clin. Pathol., March 1, 2008; 61(3): 352 - 354. [Abstract] [Full Text] [PDF]

				D. W. Reid, V. Carroll, C. O'May, A. Champion, and S. M. Kirov Increased airway iron as a potential factor in the persistence of Pseudomonas aeruginosa infection in cystic fibrosis Eur. Respir. J., August 1, 2007; 30(2): 286 - 292. [Abstract] [Full Text] [PDF]

				C. H Goss and J. L Burns Exacerbations in cystic fibrosis {middle dot} 1: Epidemiology and pathogenesis Thorax, April 1, 2007; 62(4): 360 - 367. [Abstract] [Full Text] [PDF]

				J. Zhou, E. Garber, M. Desai, and L. Saiman Compliance of Clinical Microbiology Laboratories in the United States with Current Recommendations for Processing Respiratory Tract Specimens from Patients with Cystic Fibrosis J. Clin. Microbiol., April 1, 2006; 44(4): 1547 - 1549. [Abstract] [Full Text] [PDF]

				M. R. Elkins, M. Robinson, B. R. Rose, C. Harbour, C. P. Moriarty, G. B. Marks, E. G. Belousova, W. Xuan, P. T.P. Bye, and the National Hypertonic Saline in Cystic Fibrosis A Controlled Trial of Long-Term Inhaled Hypertonic Saline in Patients with Cystic Fibrosis N. Engl. J. Med., January 19, 2006; 354(3): 229 - 240. [Abstract] [Full Text] [PDF]

				R. del Campo, M.-I. Morosini, E. G.-G. de la Pedrosa, A. Fenoll, C. Munoz-Almagro, L. Maiz, F. Baquero, R. Canton, and the Spanish Pneumococcal Infection Study Network Population Structure, Antimicrobial Resistance, and Mutation Frequencies of Streptococcus pneumoniae Isolates from Cystic Fibrosis Patients J. Clin. Microbiol., May 1, 2005; 43(5): 2207 - 2214. [Abstract] [Full Text] [PDF]

				A. Oliver, B. R. Levin, C. Juan, F. Baquero, and J. Blazquez Hypermutation and the Preexistence of Antibiotic-Resistant Pseudomonas aeruginosa Mutants: Implications for Susceptibility Testing and Treatment of Chronic Infections Antimicrob. Agents Chemother., November 1, 2004; 48(11): 4226 - 4233. [Abstract] [Full Text] [PDF]

				F. Roman, R. Canton, M. Perez-Vazquez, F. Baquero, and J. Campos Dynamics of Long-Term Colonization of Respiratory Tract by Haemophilus influenzae in Cystic Fibrosis Patients Shows a Marked Increase in Hypermutable Strains J. Clin. Microbiol., April 1, 2004; 42(4): 1450 - 1459. [Abstract] [Full Text] [PDF]

				R. L. Gibson, J. L. Burns, and B. W. Ramsey Pathophysiology and Management of Pulmonary Infections in Cystic Fibrosis Am. J. Respir. Crit. Care Med., October 15, 2003; 168(8): 918 - 951. [Abstract] [Full Text] [PDF]

				M. B. Miller and P. H. Gilligan Laboratory Aspects of Management of Chronic Pulmonary Infections in Patients with Cystic Fibrosis J. Clin. Microbiol., September 1, 2003; 41(9): 4009 - 4015. [Full Text] [PDF]

				T. Lahiri and D. A. Waltz Preimmunization Anti-Pneumococcal Antibody Levels Are Protective in a Majority of Patients With Cystic Fibrosis Pediatrics, October 1, 2001; 108(4): e62 - 62. [Abstract] [Full Text] [PDF]

				N. RENÉE CROWTHER LABIRIS, A. M. HOLBROOK, H. CHRYSTYN, S. M. MACLEOD, and M. T. NEWHOUSE Dry Powder versus Intravenous and Nebulized Gentamicin in Cystic Fibrosis and Bronchiectasis . A Pilot Study Am. J. Respir. Crit. Care Med., November 1, 1999; 160(5): 1711 - 1716. [Abstract] [Full Text]

				B. W. Ramsey, H. L. Dorkin, J. D. Eisenberg, R. L. Gibson, I. R. Harwood, R. M. Kravitz, D. V. Schidlow, R. W. Wilmott, S. J. Astley, M. A. McBurnie, et al. Efficacy of Aerosolized Tobramycin in Patients with Cystic Fibrosis N. Engl. J. Med., June 17, 1993; 328(24): 1740 - 1746. [Abstract] [Full Text]